深圳珐玛易

Shenzhen PharmaEasy Pharmaceutical Technology Co., Ltd. (PharmaEasy) is a specialized Contract Research Organization (CRO) based in Shenzhen, China, focusing on clinical pharmacology and early-phase clinical development. Established in 2016, the company provides a comprehensive suite of services including clinical trial design, bioequivalence (BE) studies, pharmacokinetics/pharmacodynamics (PK/PD) analysis, and Phase I-IV clinical trial management. PharmaEasy is particularly recognized for its expertise in navigating China's regulatory landscape, supporting pharmaceutical companies with consistency evaluations for generic drugs and the development of innovative drug candidates. The firm leverages a robust clinical pharmacology platform to bridge the gap between preclinical research and clinical application, ensuring high-quality data and efficient regulatory submissions.